Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
- Resource Type
- Article
- Source
- The Lancet; December 2021, Vol. 398 Issue: 10318 p2258-2276, 19p
- Subject
- Language
- ISSN
- 01406736; 1474547X